A proposed pediatric risk stratification method (PRiSM) for disaster preparedness

Paul E Patterson1, Matthew T Scott1, Jonathan W Chooey1

  • 1Department of Pediatrics and Division of Developmental Behavioral Pediatrics, Madigan Army Medical Center, Joint Base Lewis-McChord, Washington.

Insights

A new framework, Pediatric Risk Stratification Method (PRiSM), addresses disaster preparedness for children. It integrates medical, educational, and social factors to assess pediatric vulnerability and inform future planning.

Area of Science:

  • Public Health
  • Disaster Medicine
  • Pediatrics

Background:

  • Children represent a uniquely vulnerable population during disasters.
  • Assessing pediatric risk in disasters is complex, extending beyond immediate medical needs.
  • Current disaster preparedness lacks comprehensive tools for children's multifaceted vulnerabilities.

Purpose of the Study:

  • To review existing literature on pediatric risk and disaster preparedness.
  • To identify current methodologies for risk stratification in children.
  • To propose a novel framework for stratifying pediatric risk in disaster scenarios.

Main Methods:

  • Literature review across two databases focusing on pediatric risk and disaster preparedness.
  • Assessment of existing risk stratification methodologies across medical, social, and educational domains.
  • Development of a proposed framework integrating these multiple domains.

Main Results:

  • No existing comprehensive risk stratification tool addresses multiple domains for children.
  • Medical, educational, and social domains are critically interrelated to pediatric disaster vulnerability.
  • A proposed Pediatric Risk Stratification Method (PRiSM) uses a three-digit alphanumeric guide based on integrated data.

Conclusions:

  • The proposed PRiSM framework offers a method for pre-disaster risk stratification of children.
  • This approach can better inform disaster planning and response for pediatric populations.
  • Integrating medical, educational, and social data enhances the assessment of children's disaster preparedness needs.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
112
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
138
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
112
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.4K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
397
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
92